Humira LOE Is ‘Uncharted Territory’ As Fierce Competition Expected

Q&A With AmerisourceBergen’s Biosimilar Commercialization Director Brian Biehn

 
• By Dave Wallace
  
Empty map uncharted territory
Humira is “uncharted territory” for US biosimilars • Source: Shutterstock

More from Biosimilars

More from Products